{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:30:33Z","timestamp":1781940633195,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["code 001"],"award-info":[{"award-number":["code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Sex Behav"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10508-021-02112-7","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T19:02:36Z","timestamp":1642446156000},"page":"2603-2611","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["HIV Pre-Exposure Prophylaxis (PrEP) in a Brazilian Clinical Setting: Adherence, Adverse Events, Sexual Behavior, and Sexually Transmitted Infections"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2988-0147","authenticated-orcid":false,"given":"Ana Karina Pinto","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3112-8512","authenticated-orcid":false,"given":"Polyana","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5487-2811","authenticated-orcid":false,"given":"Dem\u00e9trius","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3703-2845","authenticated-orcid":false,"given":"Joanna d\u2019Arc Lyra","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8967-5693","authenticated-orcid":false,"given":"Ulisses Ramos","family":"Montarroyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"issue":"5","key":"2112_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/QAD.0000000000002456","volume":"34","author":"SB Ascher","year":"2020","unstructured":"Ascher, S. B., Scherzer, R., Estrella, M. M., Shigenaga, J., Spaulding, K. A., Glidden, D. V., & Jotwani, V. (2020). HIV preexposure prophylaxis with tenofovir disoproxil fumarate\/emtricitabine and changes in kidney function and tubular health. AIDS, 34(5), 699\u2013706.","journal-title":"AIDS"},{"issue":"5","key":"2112_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., & Celum, C. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399\u2013410.","journal-title":"New England Journal of Medicine"},{"key":"2112_CR3","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. (2019a). Boletim Epidemiol\u00f3gico HIV \/ Aids | 2019. Available from: http:\/\/www.aids.gov.br\/pt-br\/pub\/2019\/boletim-epidemiologico-de-hivaids-2019"},{"key":"2112_CR4","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. (2019b). Boletim Epidemiol\u00f3gico de S\u00edfilis. Ano V n-1:43. Available from: www.aids.gov.br"},{"key":"2112_CR5","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. (2020). Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Aten\u00e7\u00e3o Integral \u00e0s Pessoas com Infec\u00e7\u00f5es Sexualmente Trasmiss\u00edveis. Available from: http:\/\/www.aids.gov.br\/pt-br\/pub\/2015\/protocolo-clinico-e-diretrizes-terapeuticas-para-atencao-integral-pessoas-com-infeccoes"},{"issue":"7541","key":"2112_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/bmj.332.7541.605","volume":"332","author":"MM Cassell","year":"2006","unstructured":"Cassell, M. M., Halperin, D. T., Shelton, J. D., & Stanton, D. (2006). Hiv and risk behaviour: Risk compensation: The Achilles\u2019 heel of innovations in HIV prevention? British Medical Journal, 332(7541), 605\u2013607.","journal-title":"British Medical Journal"},{"issue":"9883","key":"2112_CR7","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., & Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (The Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. The Lancet, 381(9883), 2083\u20132090.","journal-title":"The Lancet"},{"key":"2112_CR8","doi-asserted-by":"publisher","unstructured":"Elliott, T., Sanders, E. J., Doherty, M., & Ndung\u2019u, T., Cohen, M., Patel, P., ... Fidler, S. (2019). Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: A scoping review. Journal of the International AIDS Society, 22(12), 25419. https:\/\/doi.org\/10.1002\/jia2.25419","DOI":"10.1002\/jia2.25419"},{"issue":"12","key":"2112_CR9","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner, V. A., Dalglish, S. L., Kennedy, C. E., Baggaley, R., O\u2019Reilly, K. R., Koechlin, F. M., & Grant, R. M. (2016). Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS, 30(12), 1973\u20131983.","journal-title":"AIDS"},{"issue":"27","key":"2112_CR10","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., & Glidden, D. V. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587\u20132599.","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"2112_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., & Glidden, D. V. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. Lancet Infectious Diseases, 14(9), 820\u2013829.","journal-title":"Lancet Infectious Diseases"},{"issue":"6","key":"2112_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2018-02876","volume":"9","author":"ZR Greenwald","year":"2019","unstructured":"Greenwald, Z. R., Maheu-Giroux, M., Szabo, J., Robin, J. A. B., Boissonnault, M., Nguyen, V. K., & Thomas, R. (2019). Cohort profile: L\u2019Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada. BMJ Open, 9(6), 1\u201310. https:\/\/doi.org\/10.1136\/bmjopen-2018-028768","journal-title":"BMJ Open"},{"issue":"3","key":"2112_CR13","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1016\/S2352-3018(18)30008-0","volume":"5","author":"B Grinsztejn","year":"2018","unstructured":"Grinsztejn, B., Hoagland, B., Moreira, R. I., Kallas, E. G., Madruga, J. V., Goulart, S., & Veloso, V. G. (2018). Retention, engagement prophylaxis and adherence to pre-exposure for men who have sex with men and transgender women in PrEP Brasil: 48 week results for a demonstration study. The Lancet HIV, 5(3), e136\u2013e145.","journal-title":"The Lancet HIV"},{"issue":"4","key":"2112_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bjid.2020.05.004","volume":"24","author":"B Hoagland","year":"2020","unstructured":"Hoagland, B., Torres, T. S., Bezerra, D. R. B., Geraldo, K., Pimenta, C., Veloso, V. G., & Grinsztejn, B. (2020). Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Brazilian Journal of Infectious Diseases, 24(4), 360\u2013364.","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"7","key":"2112_CR15","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/S2352-3018(19)30136-5","volume":"6","author":"E Hoornenborg","year":"2019","unstructured":"Hoornenborg, E., Coyer, L., Achterbergh, R. C. A., Matser, A., van der Loeff, M. F. S., Boyd, A., & de Vries, H. J. C. (2019). Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. The Lancet HIV, 6(7), e447\u2013e455.","journal-title":"The Lancet HIV"},{"issue":"1","key":"2112_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/QAI.0000000000001179","volume":"74","author":"SG Hosek","year":"2017","unstructured":"Hosek, S. G., Rudy, B., Landovitz, R., Kapogiannis, B., Siberry, G., Rutledge, B., & Wilson, C. M. (2017). An HIV preexposure prophylaxis demonstration project and safety study for young MSM. Journal of Acquired Immune Deficiency Syndromes, 74(1), 21\u201329.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"2112_CR17","unstructured":"IBGE. (2010). Censo demogr\u00e1fico: 2010: educa\u00e7\u00e3o e deslocamento: resultados da amostra. Available from: https:\/\/biblioteca.ibge.gov.br\/index.php\/biblioteca-catalogo?view=detalhes&id=7545"},{"issue":"12","key":"2112_CR18","doi-asserted-by":"publisher","first-page":"e81997","DOI":"10.1371\/journal.pone.0081997","volume":"8","author":"JL Marcus","year":"2013","unstructured":"Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., & Grant, R. M. (2013). No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS ONE, 8(12), e81997.","journal-title":"PLoS ONE"},{"issue":"10013","key":"2112_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., & Gill, O. N. (2016). Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): Effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet, 387(10013), 53\u201360.","journal-title":"The Lancet"},{"issue":"2","key":"2112_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10461-018-2252-9","volume":"23","author":"MA Monta\u00f1o","year":"2019","unstructured":"Monta\u00f1o, M. A., Dombrowski, J. C., Dasgupta, S., Golden, M. R., Duerr, A., Manhart, L. E., & Khosropour, C. M. (2019). Changes in sexual behavior and STI diagnoses among MSM initiating PrEP in a clinic setting. AIDS and Behavior, 23(2), 548\u2013555.","journal-title":"AIDS and Behavior"},{"key":"2112_CR21","unstructured":"NIAAA. (2004). NIAAA council approves definition of binge drinking. NIAAA Newsletter, Number 3. Available from: https:\/\/pubs.niaaa.nih.gov\/publications\/Newsletter\/winter2004\/Newsletter_Number3.pdf"},{"key":"2112_CR22","doi-asserted-by":"crossref","unstructured":"Ong, J. J., Baggaley, R. C., Wi, T. E., Tucker, J. D., Fu, H., Smith, M. K., ... Mayaud, P. (2019). Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: A systematic review and meta-analysis. JAMA Network Open, 2(12), e1917134.","DOI":"10.1001\/jamanetworkopen.2019.17134"},{"issue":"4","key":"2112_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S2055-6640(20)30312-5","volume":"4","author":"V Pilkington","year":"2018","unstructured":"Pilkington, V., Hill, A., Hughes, S., Nwokolo, N., & Pozniak, A. (2018). How safe is TDF\/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP. Journal of Virus Eradication, 4(4), 215\u2013224.","journal-title":"Journal of Virus Eradication"},{"issue":"14","key":"2112_CR24","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1097\/QAD.0000000000002347","volume":"33","author":"HM Scott","year":"2019","unstructured":"Scott, H. M., Spinelli, M., Vittinghoff, E., Morehead-Gee, A., Hirozawa, A., James, C., & Buchbinder, S. (2019). Racial\/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics. AIDS, 33(14), 2189\u20132195.","journal-title":"AIDS"},{"issue":"6","key":"2112_CR25","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/QAD.0000000000000156","volume":"28","author":"MM Solomon","year":"2014","unstructured":"Solomon, M. M., Lama, J. R., Glidden, D. V., Mulligan, K., McMahan, V., Liu, A. Y., & Grant, R. M. (2014). Changes in renal function associated with oral emtricitabine\/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS, 28(6), 851\u2013859.","journal-title":"AIDS"},{"issue":"5","key":"2112_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., & Brooks, J. T. (2012). Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. New England Journal of Medicine, 367(5), 423\u2013434.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"2112_CR27","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1186\/s12879-019-4704-x","volume":"19","author":"TS Torres","year":"2019","unstructured":"Torres, T. S., Marins, L. M. S., Veloso, V. G., Grinsztejn, B., & Luz, P. M. (2019). How heterogeneous are MSM from Brazilian cities? An analysis of sexual behavior and perceived risk and a description of trends in awareness and willingness to use pre-exposure prophylaxis. BMC Infectious Diseases, 19(1), 1067. https:\/\/doi.org\/10.1186\/s12879-019-4704-x","journal-title":"BMC Infectious Diseases"},{"issue":"5","key":"2112_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/cid\/ciy182","volume":"67","author":"MW Traeger","year":"2018","unstructured":"Traeger, M. W., Schroeder, S. E., Wright, E. J., Hellard, M. E., Fachshm, V. J. C., Doyle, J. S., & Stoov\u00e9, M. A. (2018). Effects of Pre-exposure prophylaxis for the prevention of hiv infection on sexual risk behavior in men who have sex with men: A systematic review and meta-analysis author contact details. Clinical Infectious Diseases, 67(5), 676\u2013686.","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"2112_CR29","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/cid\/civ778","volume":"61","author":"JE Volk","year":"2015","unstructured":"Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015). No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clinical Infectious Diseases, 61(10), 1601\u20131603.","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"2112_CR30","doi-asserted-by":"publisher","first-page":"e25407","DOI":"10.1002\/jia2.25407","volume":"22","author":"B Vuylsteke","year":"2019","unstructured":"Vuylsteke, B., Reyniers, T., de Baetselier, I., N\u00f6stlinger, C., Crucitti, T., Buyze, J., Laga, & M. . (2019). Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence. Journal of the International AIDS Society, 22(10), e25407.","journal-title":"Journal of the International AIDS Society"},{"issue":"7","key":"2112_CR31","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1007\/s10461-018-2290-3","volume":"23","author":"IB Zablotska","year":"2019","unstructured":"Zablotska, I. B., Vaccher, S. J., Bloch, M., Carr, A., Foster, R., Grulich, A. E., & Templeton, D. (2019). High Adherence to HIV Pre-exposure prophylaxis and No HIV seroconversions despite high levels of risk behaviour and STIs: The Australian demonstration study PrELUDE. AIDS and Behavior, 23(7), 1780\u20131789.","journal-title":"AIDS and Behavior"}],"container-title":["Archives of Sexual Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10508-021-02112-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10508-021-02112-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10508-021-02112-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T17:08:33Z","timestamp":1658164113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10508-021-02112-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["2112"],"URL":"https:\/\/doi.org\/10.1007\/s10508-021-02112-7","relation":{},"ISSN":["0004-0002","1573-2800"],"issn-type":[{"value":"0004-0002","type":"print"},{"value":"1573-2800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was reviewed and approved by the Hospital Universit\u00e1rio Oswaldo Cruz Ethics Committee, Universidade de Pernambuco, in Recife-PE, Brasil (Protocol CAAE: 00995818.9.0000.1592). It was carried out respecting all ethical principles, in compliance with the Resolution 466\/12 of the National Health Council.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}